These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4561332)

  • 21. Application of immunocompetence assays for defining immunosuppression.
    Dean JH; Padarathsingh ML; Jerrells TR
    Ann N Y Acad Sci; 1979 May; 320():579-90. PubMed ID: 110201
    [No Abstract]   [Full Text] [Related]  

  • 22. [Coombs-positive reactions in mice during transplantation of syngeneic tumors].
    Buntsevich AM; Mikheeva NV
    Biull Eksp Biol Med; 1983 May; 95(5):81-4. PubMed ID: 6850095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor metastasis in mice with reduced immune reactivity. II. Studies with a highly antigenic MCA-induced sarcoma in thymectomized and/or sub-lethally irradiated C57BL/6J mice.
    Suurküla M; Boeryd B
    Int J Cancer; 1974 Nov; 14(5):633-41. PubMed ID: 4376529
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunologic responses of the autochthonous host against tumors induced by ultraviolet light.
    Kripke ML; Fisher MS
    Adv Exp Med Biol; 1976; 66():445-9. PubMed ID: 1266675
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro studies on mechanism of the "eclipse" of cell-mediated immunity in mice bearing advanced tumors.
    Youn JK; Le François D; Barski G
    J Natl Cancer Inst; 1973 Apr; 50(4):921-6. PubMed ID: 4735758
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumour specific and embryonic antigen expression of chemically induced rat tumours.
    Baldwin RW; Glaves D; Pimm MV; Vose BM
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):715-28. PubMed ID: 4340543
    [No Abstract]   [Full Text] [Related]  

  • 27. [Development of drug-induced tumors in mice depending on the activity of the immunocompetent systems of the body].
    Neĭman IM; Finogenova MA
    Patol Fiziol Eksp Ter; 1978; (2):26-9. PubMed ID: 673472
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunologic parameters of ultraviolet carcinogenesis.
    Kripke ML; Fisher MS
    J Natl Cancer Inst; 1976 Jul; 57(1):211-5. PubMed ID: 1003502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
    Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
    Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
    [No Abstract]   [Full Text] [Related]  

  • 31. Some aspects of the cellular and humoral immune response to tumour antigens.
    Hellström KE; Hellström I
    Triangle; 1972; 11(1):23-8. PubMed ID: 4624858
    [No Abstract]   [Full Text] [Related]  

  • 32. Paw test with syngeneic tumor cells in inbred mice bearing a transplanted sarcoma.
    Wells JH; Cain WA; Bozalis JR; Wells RS; Flora JD
    Int Arch Allergy Appl Immunol; 1974; 47(2):249-60. PubMed ID: 4853561
    [No Abstract]   [Full Text] [Related]  

  • 33. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 34. Thymus deprived axenic mice. I. Humoral and cellular immunity after neonatal thymectomy.
    Salomon JC; Benveniste J
    Ann Immunol (Paris); 1974; 125(3):499-506. PubMed ID: 4213503
    [No Abstract]   [Full Text] [Related]  

  • 35. Sarcoma induction in mice by methylcholanthrene. Antigenicity tests of sarcomas induced in thymus grafted and control animals.
    Marchant J
    Br J Cancer; 1969 Jun; 23(2):383-90. PubMed ID: 5788047
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulation of transplanted 3-methylcholanthrene-induced sarcomas in mice by specific immune ahd by normal serum.
    Biddle C
    Int J Cancer; 1976 Jun; 17(6):755-64. PubMed ID: 947855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A microassay for humoral cytotoxicity demonstrating sublethal effects of antibody.
    Cleveland PH; McKhann CF; Johnson K; Nelson S
    Int J Cancer; 1974 Sep; 14(3):417-26. PubMed ID: 4459274
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of Nocardia and Mycobacterium cell-wall skeleton on autochthonous tumor grafts.
    Tokuzen R; Okabe M; Nakahara W; Azuma I; Yamamura Y
    Gan; 1975 Aug; 66(4):433-5. PubMed ID: 1102381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of tumor growth with a new synthetic ribonucleic acid.
    Fisher JC; Cooperband SR; Mannick JA
    Surg Forum; 1970; 21():122-4. PubMed ID: 4328378
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancement of tumor outgrowth by tumor-associated blocking factors.
    Hellström KE; Hellström I
    Int J Cancer; 1979 Mar; 23(3):366-73. PubMed ID: 437919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.